Rotenone induces aggregation of γ-tubulin protein and subsequent disorganization of the centrosome: Relevance to formation of inclusion bodies and neurodegeneration

Neurodegenerative disorders are characterized by progressive loss of specific neurons in the central nervous system. Although they have different etiologies and clinical manifestations, most of them share similar histopathologic characteristics such as the presence of inclusion bodies in both neurons and glial cells, which represent intracellular aggregation of misfolded or aberrant proteins. In Parkinson's disease, formation of inclusion bodies has been associated with the aggresome-related process and consequently with the centrosome. However, the significance of the centrosome in the neurodegenerative process remains obscure. In the present study, the morphological and functional changes in the centrosome induced by rotenone, a common insecticide used to produce experimental Parkinsonism, were examined both in vitro and in vivo. Aggregation of gamma-tubulin protein, which is a component of the centrosome matrix and recently identified in Lewy bodies of Parkinson's disease, was observed in primary cultures of mesencephalic cells treated with rotenone. Rotenone-treated neurons and astrocytes showed enlarged and multiple centrosomes. These centrosomes also displayed multiple aggregates of alpha-synuclein protein. Neurons with disorganized centrosomes exhibited neurite retraction and microtubule destabilization, and astrocytes showed disturbances of mitotic spindles. The Golgi apparatus, which is closely related to the centrosome, was dispersed in both rotenone-treated neuronal cells and the substantia nigra of rotenone-treated rats. Our findings suggested that recruitment of abnormal proteins in the centrosome contributed to the formation of inclusion bodies, and that rotenone markedly affected the structure and function of the centrosome with consequent induction of cytoskeleton disturbances, disassembly of the Golgi apparatus and collapse of neuronal cells.

[1]  Todd B. Sherer,et al.  Selective microglial activation in the rat rotenone model of Parkinson's disease , 2003, Neuroscience Letters.

[2]  K. Jellinger General aspects of neurodegeneration. , 2003, Journal of neural transmission. Supplementum.

[3]  I. V. Kovtun,et al.  Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Stearns,et al.  Cyclin-dependent kinase control of centrosome duplication. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Vidair,et al.  Pericentrin and γ-Tubulin Form a Protein Complex and Are Organized into a Novel Lattice at the Centrosome , 1998, The Journal of cell biology.

[6]  W. Tatton,et al.  Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.

[7]  N. Gonatas,et al.  The involvement of the Golgi apparatus in the pathogenesis of amyotrophic lateral sclerosis, Alzheimer’s disease, and ricin intoxication , 1998, Histochemistry and Cell Biology.

[8]  T. Stearns,et al.  Synaptically coupled central nervous system neurons lack centrosomal γ-tubulin , 1997, Neuroscience Letters.

[9]  M. Robinson,et al.  Cloning and expression of gamma-adaptin, a component of clathrin-coated vesicles associated with the Golgi apparatus , 1990, The Journal of cell biology.

[10]  Hiroshi Shibasaki,et al.  Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes α-Synuclein Inclusions* , 2004, Journal of Biological Chemistry.

[11]  P. Dráber,et al.  Gamma-tubulins and their functions. , 2003, TSitologiia i genetika.

[12]  Yoichi Nakazato,et al.  Pathology of the inferior olivary nucleus in patients with multiple system atrophy , 2002, Acta Neuropathologica.

[13]  Andrew H Crosby,et al.  Disruption of cellular transport: a common cause of neurodegeneration? , 2003, The Lancet Neurology.

[14]  M. Tanaka,et al.  Cell cycle aberrations by α-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies , 2003, Neurobiology of Aging.

[15]  N. Gonatas,et al.  Fragmentation of the Golgi apparatus of the ballooned neurons in patients with corticobasal degeneration and Creutzfeldt-Jakob disease , 2000, Acta Neuropathologica.

[16]  T. Ohta,et al.  Mitosis of rotenone-induced endoreduplication in Chinese hamster cells. , 1993, Idengaku zasshi.

[17]  V. Centonze,et al.  Microtubule nucleation and release from the neuronal centrosome , 1993, The Journal of cell biology.

[18]  J. Brion,et al.  Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. , 1995, The American journal of pathology.

[19]  J. Culvenor,et al.  α‐Synuclein Immunoisolation of Glial Inclusions from Multiple System Atrophy Brain Tissue Reveals Multiprotein Components , 1999, Journal of neurochemistry.

[20]  B. Oakley,et al.  Identification of γ-tubulin, a new member of the tubulin superfamily encoded by mipA gene of Aspergillus nidulans , 1989, Nature.

[21]  Pascal Kahlem,et al.  Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. , 2002, Journal of cell science.

[22]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[23]  P. Baas The neuronal centrosome as a generator of microtubules for the axon. , 1996, Current topics in developmental biology.

[24]  H. Lehrach,et al.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. , 2001, Molecular biology of the cell.

[25]  G. Stein,et al.  Cell cycle independent interaction of CDC2 with the centrosome, which is associated with the nuclear matrix-intermediate filament scaffold. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[27]  R. Himes,et al.  Rotenone inhibition of tubulin self-assembly. , 1978, Biochimica et biophysica acta.

[28]  E. Wanker,et al.  Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients. , 2001, Human molecular genetics.

[29]  P. Blumbergs,et al.  Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. , 1995, Brain : a journal of neurology.

[30]  M. Vila,et al.  The rotenone model of Parkinson's disease , 2003, Trends in Neurosciences.

[31]  R. Kopito,et al.  Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.

[32]  Yasuhiko Izumi,et al.  Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone , 2003, Neuroreport.

[33]  Smita Patel,et al.  Golgi Fragmentation Occurs in the Cells with Prefibrillar α-Synuclein Aggregates and Precedes the Formation of Fibrillar Inclusion* , 2002, The Journal of Biological Chemistry.

[34]  M. Tsuda,et al.  Effects of single cyclosporin A pretreatment on pentylenetetrazol-induced convulsion and on TRE-binding activity in the rat brain. , 1995, Brain research. Molecular brain research.

[35]  Viji M. Draviam,et al.  The Localization of Human Cyclins B1 and B2 Determines Cdk1 Substrate Specificity and Neither Enzyme Requires Mek to Disassemble the Golgi Apparatus , 2001, The Journal of cell biology.

[36]  D. Perl,et al.  Aggresome‐related biogenesis of Lewy bodies , 2002, The European journal of neuroscience.

[37]  S. Mayor,et al.  Brefeldin A causes structural and functional alterations of the trans-Golgi network of MDCK cells. , 1994, Journal of cell science.

[38]  B. Brinkley,et al.  Rotenone inhibition of spindle microtubule assembly in mammalian cells. , 1974, Experimental cell research.

[39]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[40]  K. Herrup,et al.  DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease , 2001, The Journal of Neuroscience.

[41]  P. Bywood,et al.  Mitochondrial Complex Inhibitors Preferentially Damage Substantia Nigra Dopamine Neurons in Rat Brain Slices , 2003, Experimental Neurology.

[42]  H. Iida,et al.  Functional Golgi units in microtubule-disrupted cultured atrial myocytes. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  Jean Féger,et al.  Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats , 2003, Journal of neurochemistry.

[44]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[45]  Paul C. Letourneau,et al.  Three-dimensional organization of stable microtubules and the Golgi apparatus in the somata of developing chick sensory neurons , 1995, Journal of neurocytology.

[46]  Takeshi Iwatsubo,et al.  Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia , 1998, Cell Death and Differentiation.

[47]  M. Kirschner,et al.  γ-Tubulin is a highly conserved component of the centrosome , 1991, Cell.

[48]  M. Asanuma,et al.  Glial Cells Protect Neurons Against Oxidative Stress via Transcriptional Up‐Regulation of the Glutathione Synthesis , 1999, Journal of neurochemistry.

[49]  C. Plata-salamán,et al.  Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues , 2001, Neuroscience Letters.

[50]  D. Wagner,et al.  Proteasome inhibition arrests neurite outgrowth and causes “dying‐back” degeneration in primary culture , 2003, Journal of neuroscience research.

[51]  Min Goo Lee,et al.  Dynamic Association of Proteasomal Machinery with the Centrosome , 1999, The Journal of cell biology.

[52]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[53]  L. Peris,et al.  The Cdk5‐p35 kinase associates with the Golgi apparatus and regulates membrane traffic , 2001, EMBO reports.

[54]  R. Burke,et al.  Ectopic Expression of Cell Cycle Markers in Models of Induced Programmed Cell Death in Dopamine Neurons of the Rat Substantia Nigra Pars Compacta , 2003, Experimental Neurology.

[55]  H. Braak,et al.  Nigral and extranigral pathology in Parkinson's disease. , 1995, Journal of neural transmission. Supplementum.

[56]  C. Sunkel,et al.  Gamma‐tubulin is required for the structure and function of the microtubule organizing centre in Drosophila neuroblasts. , 1995, The EMBO journal.

[57]  D. Perl,et al.  Lewy-body formation is an aggresome-related process: a hypothesis , 2004, The Lancet Neurology.

[58]  C. Olanow,et al.  Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures , 2002, Journal of neurochemistry.

[59]  M. Asanuma,et al.  Rotenone induces disassembly of the Golgi apparatus in the rat dopaminergic neuroblastoma B65 cell line , 2004, Neuroscience Letters.

[60]  Y. A. Minamishima,et al.  A possible role for centrosome overduplication in radiation-induced cell death , 2000, Oncogene.

[61]  A. Smith,et al.  The cell division cycle and the pathophysiology of Alzheimer's disease. , 1998, Neuroscience.

[62]  H. Joshi,et al.  Inhibition of microtubule nucleation at the neuronal centrosome compromises axon growth , 1994, Neuron.

[63]  Toru Itakura,et al.  Metabolic inhibition enhances selective toxicity of l-DOPA toward mesencephalic dopamine neurons in vitro , 1997, Brain Research.

[64]  S. Singer,et al.  Associations of elements of the Golgi apparatus with microtubules , 1984, The Journal of cell biology.

[65]  B. Hyman,et al.  Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.

[66]  S. Hayashi,et al.  NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains , 2000, Acta Neuropathologica.

[67]  L. Macůrek,et al.  Association of brain gamma-tubulins with alpha beta-tubulin dimers. , 2002, The Biochemical journal.

[68]  Takayuki Nojima,et al.  Induction of Centrosome Amplification and Chromosome Instability in Human Bladder Cancer Cells by p53 Mutation and Cyclin E Overexpression , 2004, Cancer Research.

[69]  I. Vincent,et al.  Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases , 2000, Neurobiology of Aging.

[70]  Yixian Zheng,et al.  γ-Tubulin is present in Drosophila melanogaster and homo sapiens and is associated with the centrosome , 1991, Cell.

[71]  Timothy J Mitchison,et al.  A Novel Action of Histone Deacetylase Inhibitors in a Protein Aggresome Disease Model , 2004, Current Biology.

[72]  Z. Mourelatos,et al.  In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. , 1996, The American journal of pathology.

[73]  G. Lazzeri,et al.  Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition , 2003, The Journal of Neuroscience.

[74]  R. Wepf,et al.  The core of the mammalian centriole contains γ-tubulin , 1995, Current Biology.

[75]  G. Banting,et al.  Polarized Distribution of the Trans‐Golgi Network Marker TGN38 During the In Vitro Development of Neocortical Neurons: Effects of Nocodazole and Brefeldin A , 1994, The European journal of neuroscience.

[76]  D. Crosby,et al.  Naturally Occurring Insecticides , 1972 .

[77]  K. Kosaka,et al.  Accumulation of human α-synuclein in different cytoskeletons in Lewy bodies in brains of dementia with Lewy bodies , 2000, Neuroscience Letters.

[78]  Takeshi Iwatsubo,et al.  Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective* , 2004, Journal of Biological Chemistry.

[79]  P. Mcgeer,et al.  Two Types of Spheroid Bodies in the Nigral Neurons in Parkinson's Disease , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[80]  David S. Park,et al.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Todd B. Sherer,et al.  An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.

[82]  S. Shin,et al.  Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors* , 2002, The Journal of Biological Chemistry.

[83]  J Q Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[84]  J. Zmuda,et al.  The Golgi apparatus and the centrosome are localized to the sites of newly emerging axons in cerebellar granule neurons in vitro. , 1998, Cell motility and the cytoskeleton.